1-8 of 8
Christopher L. Morris, MD, PhD
Close
Sort by
Journal Articles

A Patient-Derived Xenograft Model for Identifying Therapies and Defining Mechanisms of TSLP-Induced CRLF2 Signals in Ph-like B-ALL

Olivia L Francis, BS,PhD, Terry-Ann MIlford, BS, Ineavely Baez, BS, Jacqueline Coats, BS, Christopher L. Morris, MD PhD, Ross Fisher, MD, Benjamin Joseph Van Handel, BS, PhD, Ruijun Su, MD PhD, Batul T. Suterwala, MD, Shadi Farzingohar, MD, Sinisa Dovat, MD,PhD, Kimberly Payne, PhD
Journal: Blood
Blood (2015) 126 (23): 2633.
https://doi.org/10.1182/blood.V126.23.2633.2633
Published: 2015
Journal Articles

Recovery of IgG Production Following Rituximab Therapy after Allogeneic Stem Cell Transplantation

Christopher L. Morris, MD PhD, Joan Morris, MD
Journal: Blood
Blood (2014) 124 (21): 5876.
https://doi.org/10.1182/blood.V124.21.5876.5876
Published: 2014
Journal Articles

TSLP-Induced Alterations of Multiple Signaling Pathways in Primary CRLF2 B-ALL Xenografts

Parveen Shiraz, MD, Olivia Francis, MS, Ineavely Delgado, BS, Shannalee R Martinez, BS, Jacqueline Coats, MS, Katherine Salcedo Conception, BS, Karina Mayagoitia, Elizabeth Ginelli, Terry-Ann Milford, MS, Ross Fisher, MD, Christopher L. Morris, MD PhD, Xiao-bing Zhang, PhD, Ruijun Su, MD PhD, Sinisa Dovat, MD,PhD, Kimberly J Payne, PhD
Journal: Blood
Blood (2014) 124 (21): 3783.
https://doi.org/10.1182/blood.V124.21.3783.3783
Published: 2014
Journal Articles

Nitazoxanide Is Effective Therapy For Norovirus Gastroenteritis After Chemotherapy and Hematopoietic Stem Cell Transplantation (HSCT)

Joan Morris, MD, William Brown, PharmD, Christopher L. Morris, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 4581.
https://doi.org/10.1182/blood.V122.21.4581.4581
Published: 2013
Journal Articles

A Novel Pre-Clinical Xenograft Model to Study TSLP-CRLF2 Interactions in B-ALL

Ruijun Su, MD, PhD, Olivia Francis, Shannalee Martinez, Terrence Bennett, Ineavely Baez, Terry-Ann Milford, Xiao-Bing Zhang, PhD, Christopher L. Morris, MD, PhD, Sinsa Dovat, M.D., Ph.D, Kimberly J Payne, PhD
Journal: Blood
Blood (2012) 120 (21): 1498.
https://doi.org/10.1182/blood.V120.21.1498.1498
Published: 2012
Journal Articles

Two New Classes of Drugs to Target Chemotherapy Resistant and High Risk B-ALL

Cathy A. Swindlehurst, PhD, Leah Fung, PhD, Kyle W.H. Chan, PhD, Sabine Ottilie, PhD, Ashkan Shahbandi, Christopher L. Morris, MD, PhD, Oliva L Francis, Terrence Bennet, Shannalee R Martinez, Kimberly J Payne, PhD
Journal: Blood
Blood (2011) 118 (21): 2590.
https://doi.org/10.1182/blood.V118.21.2590.2590
Published: 2011
Journal Articles

Lenalidomide and Novel Immunomodulatory Drugs (IMiDs®): A New Approach to the Regulation of Erythropoiesis and Hemoglobin Synthesis in Anemia.

Laure Moutouh de Parseval, MD, Helen Brady, Ph.D, Dominique Verhelle, PhD, Laura G. Corral, MS, Emilia Glezer, BS, Christopher L. Morris, MD, PhD, Roger Chen, PhD, Kyle Chan, PhD
Journal: Blood
Blood (2005) 106 (11): 2702.
https://doi.org/10.1182/blood.V106.11.2702.2702
Published: 2005
Journal Articles

Novel Immunomodulatory Drugs (IMiDs®): A Potential, New Therapy for β-Hemoglobinopathies.

Laure Moutouh de Parseval, MD., Helen Brady, PhD., Emila Glezer, MS., Normand Richard, MS., George Muller, PhD., Christopher L. Morris, MD., PhD., Dave Stirling, PhD., Kyle Chan, PhD.
Journal: Blood
Blood (2004) 104 (11): 3740.
https://doi.org/10.1182/blood.V104.11.3740.3740
Published: 2004